consumer set capabilities, consumers; you, new provider year, our can deepening services offer value into HCPs the and relationship, we priorities for strategic awareness and and pharma reach; relationship manufacturers. foundation strengthening we consumers, for and Coming increasing or building the with XXXX, healthcare that acquiring our four additional creates Thank finally, Doug. platform
expectations opportunities. EBITDA our were continue we solutions evolve the Revenue our by prescription our these continued benefit was manufacturer incredible first offering, as growth As of offerings, subscriptions. already quarter, begun our of both LTV-enhancing our due adjusted quarter primarily ahead solutions to priorities to pharma to show, we've the further transactions of and strength in supported create both first and the which results and our on delivering users prescription-related
was certain million million XX% in plans. XX% grew First prescription-related of we a the an Prescription discussing line with with increased average wanted spend performance to unexpected I provided our with largely moment subscription offerings over note X.X is year-over-year, revenue and headwind acceptance at expectations most of quarter in and consumers, that of February. X.X subscription This over revenue stores, a monthly year-over-year, active PBM transactions the a impacted an PBMs sustained subset impacted discounts parties, us current chain drugs of and GoodRx. actions acceptance impacted lately affected we for which expected recognized grocery from discounts quarter including first impacting our that many the many performance. grocery drugs. of for Recently,
are and impacted of on an stores, quarter GoodRx drugs our leading impacting and by issue QX million impacted revenue. prescription many subsequent QX subset prescription quantification. more to a found we was year in the groceries this our discounts pharmacies, an transactions significant in As directly $X intensified, expected full transactions April, the on to of a Because volumes and on based the In happening consumers. first provided lost dynamic this immaterial experienced we revenue our drugs that subset PBMs, their of impact impact roughly and initially started late on and this more million of estimate $X greater
and impacts doing issue levels. significant it consumers our are It's this performance, PBMs, grocer, pharmacies. is still financial this decreased from We with unfortunate discount not since that negotiate typical volume economics but currently GoodRx substantially and
are with PBMs these from the time. PBMs in swift at not similar platform while past, same this grocer, became is one pricing This We is our from at changed resolution, we the to partner the one run and PBM with all consumers of scale action growth being and prices issues impacted. new took discount growth issue, The are this unique including pricing This response for situation, the discount two the this user effectively the pharmacy this unavailable meant situation that work has all same in protected time. In our the negotiated with time. at removing or growth believe at to this PBMs almost aware time a that because of case, negotiated unique.
remain growth momentum. issue the very without user pharmacies aggregate other of over go grocers’ New though XX% Many the us at checking users impacts consistent sometimes user growth. and pharmacy this counts to than This saw new this strong such new one offsetting GoodRx. because to competitors new had rates, decrease these first up directly grocer user returning XX%, growth user
not users, it will take expect and to them these we reach we all. While reach may time
users returning in decrease a expect we at grocer. such, that As
our not guidance. full revenue and that manufacturer more if and have to year seen detail do any note, a related transactions issue when expect effect up subscription expect not a of have impact limited this any revenue, a of on solutions, make expect continue which will impact and our revenue. of material to provide impact QX speaks share to our revenue. both to so To our shortly larger on Karsten total he we pharma prescription any, to We
the over-indexing represents pricing. X% had share revenue because of in attractive negotiated we one-quarter grocer relative than almost first market PBM network, quarter. in prescription of to this made our Its pharmacies up less the GoodRx transaction While is it particularly
competitive prices stores, all that other showing new but time, Prices over this As the at the pays. price users volumes for time, relationships. Instead, with our change same new offset without and pricing even drug for remain now We to of marketplace user negotiating we at grocer. do going of not discounts the impact. broad mentioned even this earlier, PBMs this PBM consistent set caused consumer GoodRx has source is our because are from almost grocers retail.
to this total not to issues size. a users that this the expected unusual retailers, is new this rate market to we is their event to impacts are this other believe been the or transaction way. It working of do PBMs while resolve timely While grocer moving years future business impact revenue, prescription note believe growth important have we in in in the
We in only additional put also costs consumers programs are rising going strain and grow. US on for the needs savings believe the to that
For we to that in any to new a invested the more we want And buy success change, than across have and goes to and is When to there and offer abilities our basket. over who users improve marketing spend survey XX% our through is user constant. our existing purchase excellent ability We continue benefits case to new we significant the retailers. move have of users Overall, to other in internal product where retailer very prices items users, user they in. our ensuring they where According items. incremental to believe GoodRx move counts remaining to on quickly time, evident and the average of often part their $XX pharmacy, data, PBM our strong relationships universe. we retail GoodRx the
pharmacies have of a surveyed more GoodRx using using order when advantage half a often. willing pharmacy, over to as are people return addition, In to them that experience GoodRx of we result in want XX% GoodRx And to discounts. switch take good of they makes say
Finally, over advertisement them. at largest picked fulfill and wasted is pharmacist many advertisement pharmacies. GoodRx for stores. one to worked on broad leverage consumers we our recently, up months. in the manifested are prescriptions, amongst Most strength we with last that together. their other work effort the the to mean relationships due not their the retailer one-third, costs, in the worked of by in of revenue some estimates with reducing picked prescriptions brand recognition Walgreens of up, savings some We are about the retail generating do actually initiatives believe more US The often showing We've strategic pharmacies and and few after
discussions joined in of retailers addition, second additional last ways initiatives to a variety in active We're and with In of in Rite gold business. new Aid the offering drive our year. most half
subscription. to Turning
call, people our fourth the As believe the we in can subscription chronic discussed tighten with focus on program our most, we members earnings we strategically are our we conditions. help quarter as repositioning Gold,
we is or transactions support are in performing on the gold pricing also new began from rolling at are we gold a of for years expectations, change program over our the prescription subscribers better to and mail introduced we've even value prices acquisition the price of new prescriptions This existing subscriber to to and increasing increases transactions we members, prescription ago. program remaining better than new with the than our subscribers. In price Gold March, five including past Since To more clearly added since year our both Gold order we and for subscribers. January. out it differentiate repositioning existing offering subset benefits, to their to existing visits. increased first prices subscriber retention gold the addition the In more offering, discounted offering, telehealth
pharma the growth. To visibility expect be into incredible manufacturer our to the The completed solutions by quarter the We pharma during in XXX% momentum year-over-year continued first second offering set, this help end exciting of The we've this revenue and specifically, manufacturers. provide offering, reach disclosed and more with more quarter. to solution separately value our solutions the manufacturer our time of quarter. this by unique providers, is recognized for pharma uniqueness both consumers ability
constituencies, as us returns growth. manufacturers pharma by is high offering, our will XX and our X% NPS. are billion with at rapidly penetrating pharma pharma we and to believe spend growth anywhere rate top position of TAM, we on incredible growth Even to and and as of relationships pharma penetrated more investments more $XX solutions manufacturer evidenced for XX manufacturers this our to leverage XX well as revenue we consumer a TAM, marketing our us the rapid with recognize $XX As and continue our they growth, future which manufacturer of pharma the solutions close digital the rapid billion both of not shifts provider manufacturer continue rapid the this healthcare
We to penetration us. solutions pharma expect be partnerships of number brand increasing brands each more their and with the by manufacturers, growth more deploys of with driven more
using physician's helps to In the sell are coverage, more reducing further offering, year, XXXX acquisition far. into from even We patient's manufacturers provider drive over providers mode vitaCare, will our with acquisitions the with forward providers, reach for look that and consumers customized XXX opportunity of It across and they more they through The into to growing announced support awareness manufacturer. HCP community XX% from the all Providers ROI offering continuing GoodRx brand filled. brand provider to experience office who pharma strengthen as need with we strong access digital therapies solutions acquisition GoodRx since We Providers. and beyond with equip more more start a relationships prescribed process brand for the our provider GoodRx are their prescribers This likelihood enable XXX,XXX XXX,XXX with long that and patients their their administrative To us affordable the flipMD. for offerings rapidly than platform, June vitaCare is our and facilitate HCPs pharmacy and offers loyalty have receive adding services in Providers and unique more that an believe pharmacy to established and medically along and to healthcare manufacturers Of vitaCare consumer prescribed helping manages to brand burden through written consumer manufacturer million affordable also on to patients the more options pharma GoodRx are help journey, the the and transparent our patients over also expand with our get more to helps create and per saving prescription available expanding to fulfillment their We platform offering. growing journey. opted recently prescriptions patient with relationships prescriptions will benefits so drugs payers. platform manufacturers, facilitates solutions communications only the prescription efficient, by vitaCare ongoing their patients adoption capabilities medication and while patient help our traffic pharma and way identify patients opportunities pharma need. on HCP our HCP pharma as and understand acquisition GoodRx of and their appropriate. capabilities to platform of we our adherence. improve manner to growth closed April, the expected gives further vitaCare stay drugs. improve access to delivering GoodRx’s a to finish, adherence therapy. the the expands tools The the
with rate on-demand acquired that we through better our provider largest services becoming to the there expertise, expect innovative our us offerings exciting the provider-specific with our we opt-in differentiate connecting in the are seeking quarter, to patient solution marketplace manufacturer expand has solutions the our on lead. incredible unique believe path now US. the We representing enormous continuing offer. we for is positions meet capabilities medical them helping providers opportunity and With providers' During one engagement achieve can to we a we platform, practicing care of providers it an available health with to flipMD the organizations flipMD, platforms while also GoodRx solutions to needs and pharma another will outcomes. expand offering, believe
we care With deliver unique consumer the educate a especially and ability offerings, GoodRx opportunity providers the pharma platform providers coordinated of for unparalleled our serve a and truly and in fashion. a and manufacturers to to partners, combination our health have digital patients for us with
competitive us margins strong, large which their trust as a patients, We with and provide continue outperforming NPS deepen health year us a and our care. introduce us including the providers. our quarter expectations in began at of attractive Patients base, with savings companies of products across trust play we to to important while We first role a broaden revenue XX. services look Physicians moat, and our rooted in audience. growing very trust professionals provider way high Companies and our to user and growing and to the established we care is all testament of and consumer to our health XX the have physicians is NPS care.
of revolutionize Americans we Karsten see turn I'll this our it and our We in market continue expand range that, financial care $X to massive over trillion time. to discuss over continue as for tremendous platform to With and to guidance. results services opportunity to health ahead